Eosinophils preserve bone homeostasis by inhibiting excessive osteoclast formation and activity via eosinophil peroxidase.
Darja AndreevKaterina KachlerMengdan LiuZhu ChenBrenda KrishnacoumarMark RingerSilke FreyGerhard KrönkeDavid VöhringerLarissa Valor-MéndezAline BozecPublished in: Nature communications (2024)
Eosinophils are involved in tissue homeostasis. Herein, we unveiled eosinophils as important regulators of bone homeostasis. Eosinophils are localized in proximity to bone-resorbing osteoclasts in the bone marrow. The absence of eosinophils in ΔdblGATA mice results in lower bone mass under steady-state conditions and amplified bone loss upon sex hormone deprivation and inflammatory arthritis. Conversely, increased numbers of eosinophils in IL-5 transgenic mice enhance bone mass under steady-state conditions and protect from hormone- and inflammation- mediated bone loss. Eosinophils strongly inhibit the differentiation and demineralization activity of osteoclasts and lead to profound changes in the transcriptional profile of osteoclasts. This osteoclast-suppressive effect of eosinophils is based on the release of eosinophil peroxidase causing impaired reactive oxygen species and mitogen-activated protein kinase induction in osteoclast precursors. In humans, the number and the activity of eosinophils correlates with bone mass in healthy participants and rheumatoid arthritis patients. Taken together, experimental and human data indicate a regulatory function of eosinophils on bone.
Keyphrases
- bone loss
- bone marrow
- rheumatoid arthritis patients
- reactive oxygen species
- oxidative stress
- rheumatoid arthritis
- transcription factor
- gene expression
- signaling pathway
- autism spectrum disorder
- adipose tissue
- systemic lupus erythematosus
- big data
- body mass index
- type diabetes
- skeletal muscle
- intellectual disability
- machine learning
- weight gain
- disease activity